Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer

por Inken Flörkemeier, Tamara N. Steinhauer, Nina Hedemann, Magnus Ölander, Per Artursson, Bernd Clement, Dirk O. Bauerschlag
Publicado 2021

ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer

por Christoph Rogmans, Jan Dominik Kuhlmann, Gerrit Hugendieck, Theresa Link, Norbert Arnold, Jörg Paul Weimer, Inken Flörkemeier, Anna-Christina Rambow, Wolfgang Lieb, Nicolai Maass, Dirk O. Bauerschlag, Nina Hedemann
Publicado 2021